跳至主要内容
临床试验/NCT00639782
NCT00639782已完成不适用

Thromboembolic Related Complications in a Randomized Trial of Previous and Current Generation Mechanical Valve Prostheses

On-X Life Technologies, Inc.56 个研究点 分布在 9 个国家目标入组 857 人开始时间: 2003年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
857
试验地点
56
主要终点
Thromboembolisms

研究概览

简要总结

The study hypothesizes that rate of thromboembolic complications of the On-X prosthesis is reduced as compared to the SJM prosthesis.

详细描述

The study is a multi-centre, randomized trial that will sequentially enroll up to 500 eligible patients in each group from up to 10 participating study centres internationally to test the hypothesis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient requires an isolated mitral or isolated aortic valve replacement. (Patients undergoing coronary artery bypass and / or concomitant repair of mitral or tricuspid valves are eligible.)
  • The patient is a candidate for receipt of a mechanical heart valve.
  • The patient (or legal guardian) has signed a study-specific informed consent form agreeing to the randomization, data collection and follow-up requirements.
  • The patient can be having a re-operative procedure, so long as the previous prosthetic valve is explanted and the patient does not become a double valve implantation patient.

排除标准

  • The patient is not a candidate to receive a mechanical heart valve.
  • The patient already has a prosthetic valve other than the valve(s) being replaced at this time.
  • The patient requires a tricuspid valve replacement.
  • The patient is enrolled in another investigative study or trial.

结局指标

主要结局

Thromboembolisms

时间窗: 5 years

Frequency of occurrence for thromboembolic events, either major or reversible, as a function of valve type.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (56)

Loading locations...

相似试验